enkephalin, leucine and Arteriosclerosis Obliterans

enkephalin, leucine has been researched along with Arteriosclerosis Obliterans in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Didenko, VA; Dudko, VA; Fedorova, NA; Zoloev, GK1
Argintaev, ES; Prum, IA; Slepushkin, VD; Sokolovich, GE; Zoloev, GK1

Trials

1 trial(s) available for enkephalin, leucine and Arteriosclerosis Obliterans

ArticleYear
[Dalargin in the treatment of arteriosclerosis obliterans of the lower extremities].
    Sovetskaia meditsina, 1990, Issue:2

    Topics: Adult; Arteriosclerosis Obliterans; Clinical Trials as Topic; Drug Evaluation; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Humans; Leg; Middle Aged; Placebos; Sympatholytics

1990

Other Studies

1 other study(ies) available for enkephalin, leucine and Arteriosclerosis Obliterans

ArticleYear
[Use of synthetic analogs of enkephalins as antiatherogenic means].
    Biulleten' eksperimental'noi biologii i meditsiny, 1989, Volume: 108, Issue:10

    Topics: Adult; Animals; Arteriosclerosis Obliterans; Cholesterol; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Humans; Lactates; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Parathyroid Hormone; Rats; Rats, Inbred Strains; Sympatholytics

1989